A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line

Biological Research

Volumn 42, Issue 3, 2009, Pages 377-389

  Aranda, Evelyn ^a   Owen, Gareth I ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Angiogenesis; EA.hy926; Endothelial; Formula; HUVEC; In vitro assay; Matrigel

Indexed keywords

ANGIOGENESIS INDUCING AGENTS; CELL LINE; COLLAGEN; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; HUMANS; LAMININ; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS;

EID: 73349137944     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602009000300012     Document Type: Article

References (64)

1. AL-ANI B, HEWETT PW, AHMED S, CUDMORE M, FUJISAWA T, AHMAD S, AHMED A (2006) The release of nitric oxide from S-nitrosothiols promotes angiogenesis. PLoS ONE 20: e25
2. ALBERT JM, CAO C, KIM KW, WILLEY CD, GENG L, XIAO D, WANG H, SANDLER A, JOHNSON DH, COLEVAS AD, LOW J, ROTHENBERG ML, LU B (2007) Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res 13: 3033-3042
3. ANTOINE N, GREIMERS R, DE ROANNE C, KUSAKA M, HEINEN E, SIMAR LJ, CASTRONOVO V (1994) AGM-1470, a potent angiogenesis inhibitor prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res 54: 2073-2076
4. BASU P, GHOSH RN, GROVE LE, KLEI L, BARCHOWSKY A (2008) Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic Acid (roxarsone). Environ Health Perspect 116: 520-523
5. BAUER J, MARGOLIS M, SCHREINER C, EDGELL CJ, AZIZKHAN J, LAZAROWSKI E, JULIANO RL (1992) In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J Cell Physiol 153: 437-449
6. BIAN W, CHEN F, BAI L, ZHANG P, QIN W (2008) Dihydrotanshinone I inhibits angiogenesis both in vitro and in vivo. Acta Biochim Biophys Sin (Shangai) 40: 1-6
7. BIJMAN MN, VAN NIEUW AMERONGEN GP, LAURENS N, VAN HINSBERGH VW, BOVEN E (2006) Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol Cancer Ther 5: 2348-2357
8. BRAHN E, BANQUERIGO ML, LEE JK, PARK EJ, FOGLER WE, PLUM SM (2008) An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor. J Rheumatol 35: 2119-2128
9. BOOTLE-WILBRAHAM CA, TAZZYMAN S, MARSHALL JM, LEWIS CE (2000) Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro. Cancer Res 60: 4719-4724
10. CAO C, ALBERT JM, GENG L, IVY PS, SANDLER A, JOHNSON DH, LU B (2006) Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer. Cancer Res 66: 11409-11415
11. CAUNT M, HU L, TANG T, BROOKS PC, IBRAHIM S, KARPATKIN S (2006) Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 66: 4125-4132
12. CHAI J, JONES MK, TARNAWSKI AS (2004) Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J 18: 1264-1266
13. COURTWRIGHT A, SIAMAKPOUR-REIHANI S, ARBISER JL, BANET N, HILLIARD E, FRIED L, LIVASY C, KETELSEN D, NEPAL DB, PEROU CM, PATTERSON C, KLAUBER-DEMORE N (2009) Secreted frizzle-related protein 2 stimulates angiogenesis via calcineurin/NFAT signaling pathway. Cancer Res 69: 4621-4628
14. DONG YL, REDDY DM, GREEN KE, CHAUHAN MS, WANG HQ, NAGAMANI M, HANKINS GD, YALLAMPALLI C (2007) Calcitonin gene-related peptide (CALCA) is a proangiogenic growth factor in the human placental development. Biol Reprod 76: 892-899
15. DORRELL MI, AGUILAR E, FRIEDLANDER M (2002) Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 43: 3500-3510
16. EDGELL CJ, MCDONALD CC, GRAHAM JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737
17. EDGELL CJ, HAIZLIP JE, BAGNELL CR, PACKENHAM JP, HARRISON P, WILBOURN B, MADDEN VJ (1990) Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol 26: 1167-1172
18. EMEIS JJ, EDGELL CJ (1988) Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926). Blood 71: 1669-1675
19. ENGEL LW, YOUNG NA, TRALKA TS, LIPPMAN ME, O'BRIEN SJ, JOYCE MJ (1978) Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352-3364
20. EREMEEVA ME, SILVERMAN DJ (1998) Rickettsia rickettsii infection of the EA.hy 926 endothelial cell line: morphological response to infection and evidence for oxidative injury. Microbiology 144: 2037-2048
21. FOLKMAN J, SHING Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
22. FRIEDLI A, FISCHER E, NOVAK-HOFER I, COHRS S, BALLMER-HOFER K, SCHUBIGER PA, SCHIBLI R, GRUNBERG J (2009) The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. Int J Biochem Cell Biol 41: 1572-1580
23. GERSTNER ER, DUDA DG, DI TOMASO E, SORENSEN G, JAIN RK, BATCHELOR TT (2007) Antiangiogenic agents for the treatment of glioblastoma. Expert Opin Investig Drugs 16: 1895-1908
24. GONDI CS, LAKKA SS, DINH DH, OLIVERO WC, GUJRATI M, RAO JS (2004) Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 1: 165-176
25. GOODWIN AM (2007) In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res 74: 172-183
26. GUIDOLIN D, VACCA A, NUSSDORFER G, RIBATTI D (2004) A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res 67: 117-124
27. JONES MK, SARFEH IJ, TARNAWSKI AS (1998) Induction of in vitro angiogenesis in the endothelial-derived cell Line, EA hy926, by Ethanol Is Mediated through PKC and MAPK. Biochem Biophys Res Commun 249: 118-123
28. KONDO S, SCHEEF EA, SHEIBANI N, SORENSON CM (2007) PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am J Physiol Cell Physiol 292: C2070-C2083
29. KONG D, LI Y, WANG Z, BANERJEE S, SARKAR FH (2007) Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67: 3310-3319
30. LAKE AC, VASSY R, DI BENEDETTO M, LAVIGNE D, LE VISAGE C, PERRET GY, LETOURNEUR D (2006) Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J Biol Chem 281: 37844-37852
31. LIU J, WANG XB, PARK DS, LISANTI MP (2002) Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem 277: 10661-10668
32. LOUTRARI H, HATZIAPOSTOLOU M, SKOURIDOU V, PAPADIMITRIOU E, ROUSSOS C, KOLISIS FN, PAPAPETROPOULOS A (2004) Perillyl Alcohol Is an Angiogenesis Inhibitor. J Pharmacol Exp Ther 311: 568-575
33. LUCERNA M, MECHTCHERIAKOVA D, KADL A, SCHABBAUER G, SCHÄFER R, GRUBER F, KOSHELNICK Y, MÜLLER HD, ISSBRÜCKER K, CLAUSS M, BINDER BR, HOFER E (2003) NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J Biol Chem 278: 11433-11440
34. MABJEESH NJ, ESCUIN D, LAVALLEE TM, PRIBLUDA VS, SWARTZ GM, JOHNSON MS, WILLARD MT, ZHONG H, SIMONS JW, GIANNAKAKOU P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3: 363-375
35. MALINDA KM, NOMIZU M, CHUNG M, DELGADO M, KURATOMI Y, YAMADA Y, KLEINMAN HK, PONCE ML (1999) Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J 13: 53-62
36. MIURA S, MATSUO Y, SAKU K (2003) Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 41: 1118-1123
37. MORALES DE, McGOWAN KA, GRANT DS, MAHESHWARI S, BHARTIYA D, CID MC, KLEINMAN HK SCHNAPER HW (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763
38. MOVAFAGH S, HOBSON JP, SPIEGEL S, KLEINMAN HK, ZUKOWSKA Z (2006) Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J 20: 1924-1926
39. NEWMAN SP, LEESE MP, PUROHIT A, JAMES DR, RENNIE CE, POTTER BV, REED MJ (2004) Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates. Int J Cancer 109: 533-540
40. NIWA S, GRAF C, BORNANCIN F (2009) Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro. Microvasc Res 77: 389-393
41. PARK MJ, KWAK HJ, LEE HC, YOO DH, PARK IC, KIM MS, LEE SH, RHEE CH, HONG SI (2007) Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-Kinase/Akt signaling pathway and AP-2 transcription factor. J Biol Chem 282: 30485-30496
42. PARK CC, MOREL JC, AMIN MA, CONNORS MA, HARLOW LA, KOCH AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167: 1644-1653
43. PASCHOALIN T, CARMONA AK, RODRIGUES EG, OLIVEIRA V, MONTEIRO HP, JULIANO MA, JULIANO L, TRAVASSOS LR (2007) Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Mol Cancer 9: 44
44. PIPILI-SYNETOS E, SAKKOULA E, HARALABOPOULOS G, ANDRIOPOULOU P, PERISTERIS P, MARAGOUDAKIS ME (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902
45. PIQUERAS L, REYNOLDS AR, HODIVALA-DILKE KM, ALFRANCA A, REDONDO JM, HATAE T, TANABE T, WARNER TD, BISHOP-BAILEY D (2007) Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27: 63-69
46. PLUDA JM (1997) Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol 24: 203-218
47. RIBATTI D, PRESTA M, VACCA A, RIA R, GIULIANI R, DELL'ERA P, NICO B, RONCALI L, DAMMACCO F (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93: 2627-2636
48. RICKER JL, CHEN Z, YANG XP, PRIBLUDA VS, SWARTZ GM, VAN WAES C (2004) 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin Cancer Res 10: 8665-8673
49. ROBINET A, FAHEM A, CAUCHARD JH, HUET E, VINCENT L, LORIMIER S, ANTONICELLI F, SORIA C, CREPIN M, HORNEBECK W, BELLON G (2005) Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 118: 343-356
50. SAIJONMAA O, NYMAN T, HOHENTHAL U, FYHRQUIST F (1991) Endothelin-1 is expressed and released by a human endothelial hybrid cell line (EA.hy 926). Biochem Biophys Res Commun 181: 529-536
51. SAKAI T, BALASUBRAMANIAN K, MAITI S, HALDER JB, SCHROIT AJ (2007) Plasmin-cleaved □≤-2-glycoprotein 1 is an inhibitor of angiogenesis. Am J Pathol 171: 1659-1669
52. SALANI D, TARABOLETTI G, ROSANÒ L, DI CASTRO V, BORSOTTI P, GIAVAZZI R, BAGNATO A (2000) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703-1711
53. SECCHIERO P, CORALLINI F, GONELLI A, DELL'EVA R, VITALE M, CAPITANI S, ALBINI A, ZAULI G (2007) Antiangiogenic activity of the MDM2 antagonist nutlin-3. Circ Res 100: 61-69
54. SMADJA DM, BIECHE I, HELLEY D, LAURENDEAU I, SIMONIN G, MULLER L, AIACH M, GAUSSEM P (2007) Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with upregulation of integrin -6. J Cell Mol Med 11: 1149-1161
55. SORIANO JV, LIU N, GAO Y, YAO ZJ, ISHIBASHI T, UNDERHILL C, BURKE TR Jr, BOTTARO DP (2004) Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain binding antagonists. Mol Cancer Ther 3: 1289-1299
56. SU Y, CUI Z, LI Z, BLOCK ER (2006) Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J 20: 1443-1451
57. SUGGS JE, MADDEN MC, FRIEDMAN M, EDGELL CJ (1986) Prostacyclin expression by a continuous human cell line derived from vascular endothelium. Blood 68: 825-829
58. SUN W, LEE TS, ZHU M, GU C, WANG Y, ZHU Y, SHYY JY (2006) Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114: 2655-2662
59. TANNER JE, FORTÈ A, PANCHAL C (2004) Nucleosomes bind fibroblast growth factor-2 for increased angiogenesis in vitro and in vivo. Mol Cancer Res 2: 281-288
60. THORNHILL MH, LI J, HASKARD DO (1993) Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926. Scand J Immunol 38: 279-286
61. VAN OOST BA, EDGELL CJ, HAY CW, MACGILLIVRAY RT (1986) Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line EA.hy926. Biochem Cell Biol 64: 699-705
62. XU H, CZERWINSKI P, HORTMANN M, SOHN HY, FÖRSTERMANN U, LI H (2008) Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res 78: 349-355
63. YAMAGISHI S, YONEKURA H, YAMAMOTO Y, KATSUNO K, SATO F, MITA I, OOKA H, SATOZAWA N, KAWAKAMI T, NOMURA M, YAMAMOTO H (1997) Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272: 8723-8730
64. ZHENG X, JIANG F, KATAKOWSKI M, ZHANG ZG, LU QE, CHOPP M (2009) ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 8: 1141-1150